165 related articles for article (PubMed ID: 36406180)
1. EBV-positive large-cell and small-cell neuroendocrine carcinoma of the nasopharynx: A case report and review of the literature.
Su Z; Yan HW; Zou GR
Oncol Lett; 2022 Dec; 24(6):464. PubMed ID: 36406180
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of One Case and Review of the Literature.
Cai Z; Lin M; Blanco AI; Liu J; Zhu H
Head Neck Pathol; 2019 Sep; 13(3):313-317. PubMed ID: 30191506
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.
Wasserman JK; Papp S; Hope AJ; Perez-Ordóñez B
Head Neck Pathol; 2018 Dec; 12(4):587-591. PubMed ID: 29302900
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal Large Cell Neuroendocrine Carcinoma Synchronized With Nasopharyngeal Squamous Cell Carcinoma: A Case Report and Review of Literature.
Lin YW; Ting CH; Chen TY; Leu YS
Ear Nose Throat J; 2022 Nov; ():1455613221138210. PubMed ID: 36345713
[TBL] [Abstract][Full Text] [Related]
5. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
[TBL] [Abstract][Full Text] [Related]
6. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
7. High Grade (Large Cell) Neuroendocrine Carcinoma of the Nasopharynx: Novel Case Report with Touch Preparation Cytology and Positive EBV Encoded Early RNA.
Sturgis CD; Burkey BB; Momin S; Hoschar AP
Case Rep Pathol; 2015; 2015():231070. PubMed ID: 26064748
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases].
Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251
[TBL] [Abstract][Full Text] [Related]
9. Five-year disease-free survival of Epstein-Barr virus-associated locoregionally advanced undifferentiated nasopharyngeal carcinoma patients treated with chemo-radiotherapy: a case report.
Wang N; Wang H; Jiang H; Bi Y; Zhao Y; He X; Cao F; Yuan Y
Ann Palliat Med; 2022 Mar; 11(3):1147-1152. PubMed ID: 35365045
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
Chan AT; Ma BB; Lo YM; Leung SF; Kwan WH; Hui EP; Mok TS; Kam M; Chan LS; Chiu SK; Yu KH; Cheung KY; Lai K; Lai M; Mo F; Yeo W; King A; Johnson PJ; Teo PM; Zee B
J Clin Oncol; 2004 Aug; 22(15):3053-60. PubMed ID: 15284255
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder neuroendocrine carcinoma: A report of two cases and literature review.
Liao Y; Cao W; Li Z; Xu X; Zhang Y; Liu Z; Miao J; Zhou Y; Zhen Z; Liu D; Li H; Chai L; Wei Y; Zhang X; Zhang L; Wang J; Tian Y
Oncol Lett; 2023 Jun; 25(6):229. PubMed ID: 37153064
[TBL] [Abstract][Full Text] [Related]
12. Small-cell neuroendocrine carcinoma of the nasopharynx: report of a rare case lacking association with Epstein-Barr virus.
Lee LY; Chang KP; Hsu CL; Chen TC; Kuo TT
Int J Surg Pathol; 2011 Apr; 19(2):199-202. PubMed ID: 18508843
[TBL] [Abstract][Full Text] [Related]
13. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.
Choi GH; Ann SY; Lee SI; Kim SB; Song IH
World J Gastroenterol; 2016 Nov; 22(41):9229-9234. PubMed ID: 27895410
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
15. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
16. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
17. Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder.
Takeda Y; Kobayashi N; Kessoku T; Okubo N; Suzuki A; Tokuhisa M; Miwa H; Udaka N; Ichikawa Y
Clin J Gastroenterol; 2022 Aug; 15(4):803-808. PubMed ID: 35653037
[TBL] [Abstract][Full Text] [Related]
18. Case report of concurrent primary malignancies of the breast and nasopharynx.
Pan X; Zhu X; Li QQ
Oncol Lett; 2012 Aug; 4(2):285-288. PubMed ID: 22844371
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
